Monoclonal Antibody Therapeutics Market to Record Immense Growth, Revenue to Surge to US $218.97 Billion by 2023
Global monoclonal antibody therapeutics market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). F. Hoffmann-La Roche Limited, Pfizer Incorporation, Bayer AG, GlaxoSmithKline Plc, and Novartis AG are some of the key vendors of monoclonal antibody therapeutics across the world. These players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers...
View full press release